Skip to main content
Signal8

O'Keeffe Charles B

SEC insider (Form 3/4/5 filer). CIK 0001378656. Director at CATALYST PHARMACEUTICALS, INC. (CPRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 14, 2025. Located in CORAL GABLES, FL.

Companies O'Keeffe Charles B has filed insider reports for

  • CATALYST PHARMACEUTICALS, INC. (CPRX): Director
O'Keeffe Charles B profile photo

O'Keeffe Charles B

CIK: 0001378656

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (66.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CATALYST PHARMACEUTICALS, INC. logo
CPRX

CATALYST PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Feb 14, 2025
    Exercise
    Direct
    4K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 27, 2024
    Exercise
    Direct
    1.3K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 10, 2024
    Exercise
    Direct
    40K shares at avg. $4.01$160K
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Dec 9, 2024
    Exercise
    Direct
    1.4K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Nov 21, 2024
    Award

    Options to purchase common stock

    Direct
    23.2K shares-
  • CATALYST PHARMACEUTICALS, INC. logo
    CPRX

    CATALYST PHARMACEUTICALS, INC.

    Nov 21, 2024
    Award

    Restricted stock units

    Direct
    2.8K shares-

1-6 of 6